Open Access iconOpen Access

ARTICLE

crossmark

Tolerance and Efficacy of Regorafenib according to UGT Pharmacogenetical Status in the Treatment of Metastatic Refractory Colorectal Cancer

Pierre-Guillaume Poureau1,2,*, Estelle Dhamelincourt2, Jessica Nguyen2, Hélène Babey2, Emmanuelle Renaud2, Margaux Geier2, Michèle Boisdron-Celle3, Jean-Philippe Metges2

1 HIA Brest, Rue Colonel Fonferrier, Gastroentérologie, Brest, 29200, France
2 CHU Morvan, 2 Av Foch, Oncologie Digestive, Brest, 29200, France
3 ICO Paul Papin, Pharmacologie Toxicologie Pharmacogénétique, 15 Rue André Bocquel, Angers, 49055, France

* Corresponding Author: Pierre-Guillaume Poureau. Email: email

TSP_ONCOLOGIE_15929.pdf

  • 1561

    View

  • 1074

    Download

  • 0

    Like

Share Link